ArticleBMC cancer2026

Impact of proton pump inhibitor use on immune-related adverse events in patients with non-small cell lung cancer: a retrospective study.

Ippei Miyamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.